# BioAge Labs, Inc. (BIOA)

**Exchange:** NASDAQ  
**Market cap:** $556M  
**Price:** $15.48 (-2.03%)

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $9M | — | -$93M | -$81M | — |
| 2024 | — | — | -$78M | -$71M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $295M | $23M | $272M | $189M | — |
| 2024 | $358M | $35M | $323M | $354M | $9M |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$82M | $719,000 | -$82M |
| 2024 | -$52M | $366,000 | -$52M |
| 2023 | -$37M | $166,000 | -$38M |

Source: [CompaniesByCap](https://companiesbycap.com/company/BIOA)